Discover Magazine11 小时
FDA Approves Opioid Alternative for Pain Relief That Is Non-Addictive
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
FDA approves opiate-alternative acute pain management drug, local experts share their thoughts
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
FDA approves new pain drug Journavx as opioid alternative
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...
FDA approves first new non-opioid pain pill in decades
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
FDA approves new type of non-opioid pain medication in two decades
The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...
US drug regulator approves first new type of pain pill in more than 20 years
The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...
thecardiologyadvisor.com5 天
Chronic Widespread Pain and Atherosclerosis May Share a Genetic Pathway
A common genetic pathway may account for increased risk for atherosclerotic disease in patients with chronic widespread musculoskeletal pain. Chronic widespread pain (CWP) and atherosclerotic disease ...
FDA approves first new non-opioid pain pill in 20 years—how it works
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.